@FiercePharma: Crain's NY predicts Forest Labs will prevail in today's shareholder vote, but Icahn isn't known for giving up easily. Story | Follow @FiercePharma
> Paladin has agreed to buy Labopharm, a Canadian company specializing in controlled release drugs, for about $20.4 million in an effort to strengthen its pain franchise. News | Report
> Abbott Laboratories got the FDA nod for two longer-acting doses of its drug Lupron for use in treating premature puberty. Story
> The Generic Pharmaceutical Association spent about $508,000 on lobbying during the second quarter, focusing primarily on patent issues and healthcare reform provisions covering biosimilar drugs. Item
> Continuing its share-buyback program, AstraZeneca purchased 750,000-plus shares at a price of 2845 pence per share. Article
> Shortages of some hospital drugs have grown so extreme that gray-market scalpers are hawking supplies at exorbitant prices. Story
> Moody's Investors Service hiked its outlook on Biogen Idec to "positive" from "stable" and affirmed its Baa3 rating on $1.1 billion in debt. News
> Hospira shares rose after a Citi Investment Research analyst upgraded them to "hold" from "sell." Piece
Biotech News
@FierceBiotech: Zogenix plots marketing app as pain drug clears PhIII. More | Follow @FierceBiotech
@JohnCFierce: WSJ article on online "dating service" approach to matching approved drugs to new uses. Piece | Follow @JohnCFierce
@RyanMFierce: Far out. Boston Herald reports budding prospects of a Mass. biotech that has sequenced the cannabis genome. Item | Follow @RyanMFierce
@MaureenFierce: Only half of doctors surveyed were aware Brilinta was approved. Most won't switch patients from Plavix. #sermosurveys. Report | Follow @MaureenFierce
> Amarin shares slide as investors fret over fate of AMR101 patent. More
> Stanford investigators match old drugs with new medical uses. Story
> Gentium tanks after it yanks drug apps on FDA data concerns. Report
Manufacturing News
> Turkeys drive Congress to antibiotic action. News
> FDA aims for quality through regulatory science. Story
> The other dark side of Merck's 13,000 layoffs. More
> Recalls expert: Keep a close eye on regulators. Article
> New cause found in most recent Tylenol recall. Details
Vaccine News
> Carbohydrate key to C. diff vaccine. Details
> Novel antibodies could lead to AIDS vaccine. More
> USAID, IDRI form malaria vax collaboration. Report
> TapImmune, Mayo Clinic announce PhI breast cancer vaccine trial. News
> Inviragen, U of Texas land $3M grant for chikungunya vaccine. Article
And Finally... Smokers have a higher risk of bladder cancer than previously believed, perhaps because of new chemicals in cigarettes. Report